Equities Analysts Issue Forecasts for SRC Energy Inc’s FY2020 Earnings (NYSEAMERICAN:SRCI)

SRC Energy Inc (NYSEAMERICAN:SRCI) – Equities research analysts at Capital One Financial cut their FY2020 EPS estimates for shares of SRC Energy in a research note issued to investors on Tuesday, August 27th, Zacks Investment Research reports. Capital One Financial analyst P. Johnston now forecasts that the oil and natural gas company will earn $0.66 per share for the year, down from their prior estimate of $0.85. Capital One Financial currently has a “Overweight” rating on the stock.

Equities Analysts Issue Forecasts for Conn’s Inc’s FY2020 Earnings (NASDAQ:CONN)

Conn’s Inc (NASDAQ:CONN) – Oppenheimer raised their FY2020 EPS estimates for Conn’s in a report released on Tuesday, September 3rd, according to Zacks Investment Research. Oppenheimer analyst B. Nagel now forecasts that the specialty retailer will post earnings of $2.82 per share for the year, up from their previous forecast of $2.77. Oppenheimer also issued estimates for Conn’s’ Q4 2020 earnings at $1.02 EPS.

Equities Analysts Offer Predictions for Pinnacle Financial Partners’ Q3 2019 Earnings (NASDAQ:PNFP)

Pinnacle Financial Partners (NASDAQ:PNFP) – Analysts at SunTrust Banks upped their Q3 2019 earnings per share (EPS) estimates for shares of Pinnacle Financial Partners in a research note issued on Wednesday, September 11th, according to Zacks Investment Research. SunTrust Banks analyst J. Demba now expects that the financial services provider will post earnings of $1.38 per share for the quarter, up from their prior forecast of $1.33. SunTrust Banks also issued estimates for Pinnacle Financial Partners’ Q4 2019 earnings at $1.23 EPS, FY2019 earnings at $5.26 EPS, Q1 2020 earnings at $1.28 EPS, Q2 2020 earnings at $1.39 EPS, Q3 2020 earnings at $1.42 EPS, Q4 2020 earnings at $1.41 EPS and FY2020 earnings at $5.50 EPS.

Equities Analysts Lift Earnings Estimates for Chesapeake Energy Co. (NYSE:CHK)

Chesapeake Energy Co. (NYSE:CHK) – Imperial Capital increased their Q3 2019 earnings estimates for shares of Chesapeake Energy in a note issued to investors on Wednesday, September 11th, Zacks Investment Research reports. Imperial Capital analyst J. Wangler now anticipates that the oil and gas exploration company will post earnings per share of ($0.12) for the quarter, up from their previous estimate of ($0.13). Imperial Capital also issued estimates for Chesapeake Energy’s Q4 2019 earnings at ($0.07) EPS, FY2019 earnings at ($0.30) EPS and FY2020 earnings at ($0.10) EPS.

Equities Analysts Increase Earnings Estimates for Biomerica, Inc. (NASDAQ:BMRA)

Biomerica, Inc. (NASDAQ:BMRA) – Equities researchers at B. Riley raised their Q1 2020 earnings per share estimates for Biomerica in a note issued to investors on Tuesday, September 10th, according to Zacks Investment Research. B. Riley analyst A. D’silva now anticipates that the company will earn ($0.06) per share for the quarter, up from their previous forecast of ($0.08). B. Riley currently has a “Buy” rating and a $6.00 target price on the stock. B. Riley also issued estimates for Biomerica’s Q2 2020 earnings at ($0.08) EPS, Q3 2020 earnings at ($0.06) EPS, FY2020 earnings at ($0.27) EPS and FY2022 earnings at $0.75 EPS.

Equities Analysts Set Expectations for Cellectis SA’s FY2019 Earnings (NASDAQ:CLLS)

Cellectis SA (NASDAQ:CLLS) – Stock analysts at Oppenheimer upped their FY2019 earnings per share (EPS) estimates for Cellectis in a research note issued to investors on Wednesday, August 21st, Zacks Investment Research reports. Oppenheimer analyst H. Singh now anticipates that the biotechnology company will post earnings per share of ($2.71) for the year, up from their previous estimate of ($2.77). Oppenheimer also issued estimates for Cellectis’ Q4 2019 earnings at ($0.63) EPS, FY2020 earnings at ($2.90) EPS, FY2021 earnings at ($3.12) EPS, FY2022 earnings at ($3.21) EPS and FY2023 earnings at ($0.59) EPS.

Equities Analysts Raise Earnings Estimates for Brigham Minerals Inc (NYSE:MNRL)

Brigham Minerals Inc (NYSE:MNRL) – Equities researchers at Piper Jaffray Companies increased their Q3 2019 earnings per share (EPS) estimates for shares of Brigham Minerals in a note issued to investors on Tuesday, September 17th. Piper Jaffray Companies analyst P. Hammond now forecasts that the company will post earnings of $0.46 per share for the quarter, up from their previous estimate of $0.45. Piper Jaffray Companies also issued estimates for Brigham Minerals’ Q4 2019 earnings at $0.59 EPS and FY2019 earnings at $1.30 EPS.

Equities Analysts Cut Earnings Estimates for Weingarten Realty Investors (NYSE:WRI)

Weingarten Realty Investors (NYSE:WRI) – Analysts at SunTrust Banks lowered their Q3 2019 earnings per share estimates for Weingarten Realty Investors in a research report issued to clients and investors on Thursday, August 22nd, according to Zacks Investment Research. SunTrust Banks analyst K. Kim now expects that the real estate investment trust will earn $0.53 per share for the quarter, down from their prior estimate of $0.54. SunTrust Banks also issued estimates for Weingarten Realty Investors’ Q4 2019 earnings at $0.52 EPS, FY2019 earnings at $2.09 EPS, FY2020 earnings at $2.08 EPS, FY2021 earnings at $2.20 EPS, FY2022 earnings at $2.34 EPS and FY2023 earnings at $2.45 EPS.

Equities Analysts Set Expectations for Chewy Inc’s Q1 2021 Earnings (NYSE:CHWY)

Chewy Inc (NYSE:CHWY) – Equities researchers at Wedbush lowered their Q1 2021 earnings estimates for Chewy in a report issued on Wednesday, September 18th. Wedbush analyst S. Basham now forecasts that the company will post earnings per share of $0.02 for the quarter, down from their prior forecast of $0.03. Wedbush currently has a “Hold” rating and a $30.00 price target on the stock. Wedbush also issued estimates for Chewy’s FY2022 earnings at $0.24 EPS.

Equities Analysts Boost Earnings Estimates for Fate Therapeutics Inc (NASDAQ:FATE)

Fate Therapeutics Inc (NASDAQ:FATE) – Equities research analysts at Piper Jaffray Companies raised their Q3 2019 earnings estimates for shares of Fate Therapeutics in a report issued on Sunday, September 15th. Piper Jaffray Companies analyst E. Tenthoff now anticipates that the biopharmaceutical company will post earnings per share of ($0.36) for the quarter, up from their prior estimate of ($0.37). Piper Jaffray Companies currently has a “Overweight” rating and a $28.00 price target on the stock. Piper Jaffray Companies also issued estimates for Fate Therapeutics’ Q4 2019 earnings at ($0.34) EPS, FY2019 earnings at ($1.36) EPS, Q1 2020 earnings at ($0.36) EPS, Q2 2020 earnings at ($0.38) EPS, Q3 2020 earnings at ($0.38) EPS, Q4 2020 earnings at ($0.42) EPS and FY2020 earnings at ($1.53) EPS.

error: Content is protected !!